Laser palliation of oral manifestations of human immunodeficiency virus infection

Journal of the American Dental Association

Volumn 133, Issue 5, 2002, Pages 591-598

  Convissar, Robert A ^a,b  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AIDS RELATED COMPLEX; APHTHOUS STOMATITIS; ARTICLE; CASE REPORT; HUMAN; KAPOSI SARCOMA; LASER; MALE; MIDDLE AGED; MOUTH DISEASE; PALLIATIVE THERAPY; VIRUS INFECTION;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; HUMANS; LASERS; MALE; MIDDLE AGED; MOUTH DISEASES; PALLIATIVE CARE; PAPILLOMAVIRUS INFECTIONS; SARCOMA, KAPOSI; STOMATITIS, APHTHOUS;

EID: 0036580660     PISSN: 00028177     EISSN: None     Source Type: Journal    
DOI: 10.14219/jada.archive.2002.0234     Document Type: Article

References (42)

1. Centers for Disease Control and Prevention. HIV/AIDS surveillance report. Atlanta: Centers for Disease Control and Prevention; 2001:1-42.
2. AIDS Institute. Oral health care for adults, adolescents, and children with HIV infection. Albany, N.Y.: New York State Department of Health; 1998.
3. Laskaris G, Potouridou I, Laskaris M, Stratigos J. Gingival lesions of HIV infection of 178 Greek patients. Oral Surg Oral Med Oral Pathol 1992;74:168-71.
4. Mascarenhas AM, Smith SR. Factors associated with utilization of care for oral lesions in HIV disease. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999;87:708-13.
5. Glick M, Muzyka BC, Lurie D, Salkin LM. Oral manifestations associated with HIV-related disease as markers for immune suppression and AIDS. Oral Surg Oral Med Oral Pathol 1994;77:344-9.
6. The principles of ethics and code of professional conduct. American Dental Association, Chicago: ADA;2000.
7. Americans with Disabilities Act. 4 USC §401(2)(B) (1990).
8. Scully C, McCarthy G. Management of oral health in persons with HIV infection. Oral Surg Oral Med Oral Pathol 1992;73:215-25.
9. Itin PH, Lautenschlager S, Fluckiger R. Rufli T. Oral manifestations in HIV-infected patients: diagnosis and management. J Am Acad Dermatol 1993;29:749-60.
10. Greenspan D, Greenspan JS. Management of the oral lesions of HIV infection. JADA 1991;122(9):26-32.
11. Little J, Palace D. Dental management of the medically compromised patient. 4th ed. St. Louis: Mosby; 1993:14-8, 289-315.
12. Flaitz C, Nichols C, Hicks M. An overview of the oral manifestations of AIDS-related Kaposi's sarcoma. Compend Contin Educ Dent 1995;16:136-48.
13. USPHS/IDSA Prevention of Opportunistic Infections Working Group. 1997 USPHS/ISDA guidelines for the prevention of opportunistic infections in persons infected with the human immuno-deficiency virus. MMWR Recomm Rep 1997;461(RR-12):19.
14. American Academy of Oral Medicine. Clinician's guide to treatment of HIV-infected patients. New York: American Academy of Oral Medicine; 1996.
15. Strauss RA. Laser management of discrete lesions. In: Catone G, Alling C, eds. Laser applications in oral and maxillofacial surgery. Philadelphia: Saunders; 1997:131-3.
16. Pick RM. Using lasers in clinical dental practice. JADA 1993; 124(2):37-47.
17. Miller M, Truhe T. Lasers in dentistry: an overview. JADA 1993; 124(2):32-5.
18. Kutsch VK. Lasers in dentistry: comparing wavelengths. JADA 1993;124(2):49-54.
19. Rooney J, Midda M, Leeming J. A laboratory investigation of the bactericidal effect of an NdYAG laser. Br Dent J 1994;176(2):61-4.
20. Whitters CJ, McFarlane TW, MacKenzie D, Mosley H, Strang R. The bactericidal activity of pulsed Nd:YAG laser radiation in vitro. Lasers Med Sci 1994;9:297-303.
21. Neill ME, Mellonig JT. Clinical efficacy of the Nd:YAG laser for combination periodontitis therapy. Pract Periodontics Aesthet Dent 1997;9(6 supplement):1-5.
22. Radvar M, Creanor SL, Gilmour WH, et al. An evaluation of the effects of an Nd:YAG laser on subgingival calculus, dentine, and cementum: an in vitro study. J Clin Periodontol 1995;22:71-7.
23. Henry C, Dyer B, Judy M. In vitro phototoxicity of bacteroides species by argon laser (abstract 873). J Dent Res 1991;70:374.
24. Henry C, Dyer B, Judy M, Wagner M. Sensitivity to argon laser among species of black pigmented bacteria (abstract 1094). J Dent Res 1993;72:240.
25. Coffelt DW, Cobb CM, MacNeill S, Rapley JW, Killoy WJ. Determination of energy density threshold for laser ablation of bacteria: an in vitro study. J Clin Periodontol 1997;24:1-7.
26. Pinero J. Nd:YAG assisted periodontal curettage to prevent bacteremia before cardiovascular surgery (abstract). Lasers Surg Med 1997;9:13.
27. Hughes PS, Hughes AP. Absence of human papillomavirus DNA in the plume of erbium:YAG laser-treated warts. J Am Acad Dermatol 1998;38(3):426-8.
28. Kunachak S, Sithisam P, Kulapaditharom B. Are laryngeal papilloma virus-infected cells viable in the plume derived from a continuous mode carbon dioxide laser, and are they infectious? A preliminary report on one laser mode. J Laryngol Otol 1996;110(11):1031-3.
29. Lucatorto FM, Sapp JP. Treatment of oral Kaposi's sarcoma with a sclerosing agent in AIDS patients. Oral Surg Oral Med Oral Pathol 1993;75:192-8.
30. Chockley B, Coke J. Treatment modalities for intraoral Kaposi's sarcoma: report of case. Spec Care Dentist 1991;11(6):231-3.
31. Ficarra G, Berson AM, Silverman S Jr, et al. Kaposi's sarcoma of the oral cavity: a study of 134 patients with a review of the pathogenesis, epidemiology, clinical aspects, and treatment. Oral Surg Oral Med Oral Pathol 1988;66:543-50.
32. Colvard M, Kuo P. Managing aphthous ulcers: laser treatment applied. JADA 1991;122(7):51-3.
33. Convissar RA, Massoumi-Sourey M. Recurrent aphthous ulcers: etiology and laser ablation. Gen Dent 1992;40:512-5.
34. Physicians' desk reference. 52nd ed. Montvale, N.J.: Medical Economics; 1998:554-8.
35. Premoli-De-Percoco G, Ramirez JL, Galindo I. Correlation between HPV types associated with oral squamous cell carcinoma and cervicovaginal cytology: an in situ hybridization study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998;86:77-81.
36. Al-Bakkal G, Ficarra G, McNeill K, Eversole LR, Sterrantino G, Birek C. Human papillomavirus type 16 E6 gene expression in oral exophytic epithelial lesions as detected by in situ rtPCR. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999;87:197-208.
37. Ceballos-Salobrena A, Aguirre-Urizar JM, Bagan-Sebastian JV. Oral manifestations associated with human immunodeficiency virus infection in a Spanish population. J Oral Pathol Med 1996;25:523-6.
38. Aguirre JM, Echebarria M, Ocina E, Ribacoba L, Mortejo M. Reduction of HIV-associated oral lesions after highly active antiretroviral therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999;88:114-5.
39. Lamster IB, Grbic JT, Bucklan RS, Mitchell-Lewis D, Reynolds HS, Zambon JJ. Epidemiology and diagnosis of HIV-associated periodontal diseases. Oral Dis 1997;3(supplement 1):S141-8.
40. Moore LV, Moore WE, Riley C, Brooks CN, Burmeister JA, Smibert RM. Periodontal microflora of HIV positive subjects with acquired immune deficiency syndrome J Periodont 1993:64:48-56.
41. Murray PA. HIV disease as a risk factor for periodontal disease. Compendium 1994;15(8):1052-64.
42. Moritz A, Gutknecht N, Doertbudak O, et al. Bacterial reduction in periodontal pockets through irradiation with a diode laser: a pilot study. J Clin Laser Med Surg 1997;15:33-7.